Royce & Associates LP lessened its holdings in AAC Holdings Inc (NYSE:AAC) by 5.5% during the fourth quarter, HoldingsChannel.com reports. The fund owned 178,993 shares of the company’s stock after selling 10,407 shares during the period. Royce & Associates LP’s holdings in AAC were worth $1,611,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. San Francisco Sentry Investment Group CA acquired a new position in AAC in the 4th quarter valued at $34,235,000. Mondrian Investment Partners LTD grew its holdings in AAC by 16.5% in the 4th quarter. Mondrian Investment Partners LTD now owns 438,655 shares of the company’s stock valued at $3,948,000 after buying an additional 62,026 shares in the last quarter. EAM Investors LLC acquired a new position in AAC in the 3rd quarter valued at $1,977,000. State Street Corp grew its holdings in AAC by 7.4% in the 2nd quarter. State Street Corp now owns 164,658 shares of the company’s stock valued at $1,139,000 after buying an additional 11,338 shares in the last quarter. Finally, Northern Trust Corp grew its holdings in AAC by 4.6% in the 2nd quarter. Northern Trust Corp now owns 128,741 shares of the company’s stock valued at $893,000 after buying an additional 5,709 shares in the last quarter. 64.27% of the stock is currently owned by hedge funds and other institutional investors.
AAC has been the topic of a number of research reports. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $14.00 price objective on shares of AAC in a report on Thursday, November 16th. Zacks Investment Research raised AAC from a “hold” rating to a “buy” rating and set a $11.00 price objective on the stock in a report on Tuesday. ValuEngine raised AAC from a “hold” rating to a “buy” rating in a report on Friday, February 23rd. Finally, TheStreet lowered AAC from a “c-” rating to a “d+” rating in a report on Thursday, February 22nd. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $10.33.
In other news, Director David C. Kloeppel sold 10,000 shares of the stock in a transaction on Monday, January 29th. The stock was sold at an average price of $9.50, for a total transaction of $95,000.00. Following the sale, the director now directly owns 202,580 shares of the company’s stock, valued at approximately $1,924,510. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Corporate insiders own 33.99% of the company’s stock.
AAC Holdings Inc (NYSE AAC) opened at $10.10 on Wednesday. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 1.62. AAC Holdings Inc has a 1-year low of $5.99 and a 1-year high of $13.06. The company has a market capitalization of $233.72, a price-to-earnings ratio of 16.30 and a beta of 1.62.
AAC (NYSE:AAC) last issued its quarterly earnings data on Wednesday, February 21st. The company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of $0.04 by $0.06. The firm had revenue of $86.10 million for the quarter, compared to analyst estimates of $72.82 million. AAC had a positive return on equity of 9.25% and a negative net margin of 6.48%. The company’s revenue for the quarter was up 19.0% on a year-over-year basis. During the same period in the prior year, the firm posted $0.15 EPS. equities research analysts predict that AAC Holdings Inc will post 0.7 earnings per share for the current year.
AAC Holdings, Inc is a provider of inpatient and outpatient substance abuse treatment services for individuals with drug and alcohol addiction. The Company performs drug testing and diagnostics laboratory services and provides physician services to its clients. As of June 30, 2016, the Company operated 12 residential substance abuse treatment facilities located throughout the United States, focused on delivering clinical care and treatment solutions across 1,139 beds, which includes 636 licensed detoxification beds, and 18 standalone outpatient centers.
Want to see what other hedge funds are holding AAC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AAC Holdings Inc (NYSE:AAC).